Find out how taking Disease-Modifying Therapies (DMTs) can play an important role in living well with MS. Explore how medications compliment Overcoming MS’s recommendations, and the things to consider before taking DMTs to help make an informed decision. Anyone affected by MS may find this information useful.
Jump to tools and resourcesA group of medicines called Disease-Modifying Therapies (DMTs) are used to manage MS. They are also sometimes known as Disease-Modifying Drugs (DMDs). Taking DMTs can play an important role in living well with MS. They can slow progression and reduce the risk of relapse. This can support overall health and wellbeing.
A range of DMTs are available, each with different benefits and side effects. A neurologist will consider your case and may talk to you about possibly using a DMT. Choosing whether to take a DMT is a personal decision and can depend on:
In people with MS, studies have shown that DMTs have a beneficial effect. They:
DMTs cannot improve existing symptoms. This is because they cannot repair nerve damage caused by MS. Instead, they aim to reduce the risk of further nerve damage and additional symptoms.
There are lots of different types of DMTs and more are being developed all the time. The table below shows DMTs which are licensed for use in MS. They are approved by the US’s Food and Drug Administration (FDA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
|
Generic drug name |
Brand name |
How the treatment is given |
Licensed for people with: |
|
Alemtuzumab |
Lemtrada |
Infusion |
Relapsing MS |
|
Cladribine |
Mavenclad |
Oral |
Relapsing MS Secondary Progressive MS |
|
Dimethyl fumarate |
Tecfidera |
Oral |
Relapsing MS |
|
Diroximel fumarate |
Vumerity |
Oral |
Relapsing MS |
|
Fingolimod |
Gilenya Tascenso ODT |
Oral |
Relapsing MS |
|
Glatiramer acetate |
Brabio Copaxone Glatopa |
Injection |
Relapsing MS |
|
Interferon beta-1a |
Avonex Rebif |
Injection |
Relapsing MS |
|
Interferon beta-1b |
Betaferon Betaseron Extavia |
Injection |
Relapsing MS |
|
Monomethyl fumurate |
Bafiertam |
Oral |
Relapsing MS |
|
Natalizumab |
Tyruko Tysabri |
Infusion, injection |
Relapsing MS |
|
Ocrelizumab |
Ocrevus |
Infusion |
Relapsing MS Primary Progressive MS |
|
Ofatumumab |
Kesimpta |
Injection |
Relapsing MS |
|
Ozanimod |
Zeposia |
Oral |
Relapsing MS |
|
Peginteferon beta-1a |
Plegridy |
Injection |
Relapsing MS |
|
Ponesimod |
Ponvory |
Oral |
Relapsing MS |
|
Siponimod |
Mayzent |
Oral |
Relapsing MS Secondary Progressive MS |
|
Teriflunomide |
Aubagio |
Oral |
Relapsing MS |
|
Ublituximab |
Briumvi |
Infusion |
Relapsing MS |
What it means for people living with MS: Together, this evidence suggests that taking DMTs can benefit progression, relapse and brain health. It may help people with MS remain independent and engaged in daily life over time.
Disease-Modifying Therapies (DMTs) play a key part in managing MS. They are very effective at preventing relapses, and some also protect against disability worsening over time. They aim to protect your body from further damage caused by MS but will often do less to help with daily symptoms. They are particularly effective when taken at an early stage in the disease. However, they won’t be the right choice for everyone. Lifestyle changes combined with medications work well as they can make you feel better now while also protecting your future health.
Dr. Jonathan White MBChB MRCOG
For me, living with MS has meant navigating different chapters. Returning to a DMT after a relapse was a decision I didn’t take lightly. Combining treatment with the Overcoming MS lifestyle gives me genuine reassurance and agency. I know I’m making proactive, empowered choices to look after my future.
Rabiah Coon
To make an informed decision about taking DMTs:
You may find these Overcoming MS webpages and resources helpful:
There’s more to discover. Sign up for our emails for practical tips, personal stories and evidence-informed insights to help you live well with MS.
Disease-Modifying Therapies, usually shortened to DMTs, are medicines that can help manage multiple sclerosis. They can reduce the number and severity of relapses, reduce new MS activity seen on MRI scans and, for some people, slow disease progression over time. They are also sometimes called Disease-Modifying Drugs or DMDs.
No. There is currently no cure for MS. DMTs aim to reduce the risk of relapse, slow disease progression, reduce future MS activity and protect long-term neurological health. They cannot repair nerve damage that has already happened and may not improve existing day-to-day symptoms.
DMTs are not primarily used to relieve symptoms such as fatigue, pain, stiffness or bladder problems. Their purpose is to reduce risk of relapse, disease progression and future nerve damage. Other medications, rehabilitation and lifestyle approaches may be recommended to help manage day-to-day symptoms instead.
Yes. DMTs and healthy lifestyle changes can have complementary roles. A DMT aims to reduce MS disease progression and protect future health. Lifestyle choices such as eating well, keeping active, managing stress, avoiding smoking and maintaining healthy vitamin D levels can support wider health and wellbeing. Lifestyle changes should not be treated as a replacement for medical advice. However, combining medication with lifestyle changes can give you the best chance of living well with MS.
It is more common for DMTs to be offered to people with active relapsing forms of MS. Some treatments may also be available for people with active secondary progressive MS or early primary progressive MS. Eligibility depends on factors such as your type of MS, relapses, MRI results, previous treatment and the prescribing criteria where you live.
If your MS is active, your neurologist or MS team may recommend starting treatment soon after diagnosis. Earlier treatment may help prevent inflammatory damage before it causes further problems, but the right timing and treatment will depend on your individual circumstances. Ask your MS team to explain the potential benefits and risks of starting now, delaying treatment or not taking a DMT.
There is no single DMT that is right for everyone. Your decision may be influenced by how active your MS is, how effectively each treatment controls MS activity, possible risks and side effects, how the treatment is taken and monitored, whether you have any other health conditions and any other medication you are already taking.
Your MS team can help you compare the possible options. A DMT decision aid can also help you choose.
You may need to talk to your MS team about changing treatment if your MS remains active, you experience difficult side effects, your circumstances change or a different treatment becomes more suitable. Do not stop a DMT without speaking to your MS team first. Stopping some treatments suddenly can lead to renewed or increased MS activity.
Some DMTs can have an impact on fertility, pregnancy or breast-feeding. This can apply to both women and men taking certain treatments. Speak to your MS team before trying to conceive and before stopping medication, so you can agree a plan that balances pregnancy considerations with the risk of MS activity.
No. Availability and eligibility vary according to the type and activity of MS, previous treatments, local prescribing rules and the healthcare system in your country. In England, treatment decisions are informed by individual NICE guidance and the NHS England DMT treatment algorithm. Other UK nations and countries may use different criteria.
We’re wanting to improve content for our users, do you have 20 seconds to help us with with two quick questions?
Find information on ways to improve your health by eating well, moving your body, optimising your vitamin D levels and more.
Last review: November 2026 Next review: November 2029